Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601 Americans were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2 to predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Women’s Health Month
May is Women’s Health Month, a time when we focus on the importance of taking care of ourselves and our health. This month is an…
Read Article
Military Spouse Appreciation Day
May 10 marks the celebration of Military Spouse Appreciation Day, a time to honor and recognize the immense contributions made by military spouses in supporting…
Read Article
Melanoma and Skin Cancer Awareness Month
Melanoma is an aggressive form of skin cancer. In addition to the skin, melanoma may also occur in mucous membranes – thin, moist layers of tissue that cover surfaces…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
